about venturemed group

The company was founded in 2012, by vascular surgeon, John P. Pigott, MD, to design, develop and market cost-effective interventional devices to improve the treatment of peripheral artery disease. Our innovative product platforms are designed to reduce procedural costs and improve clinical outcomes.

Our Flex® Scoring Catheter has the flexibility to treat the complete range of peripheral vessel diameters and lesion lengths and has been described as a safe, efficient and intuitive tool for the treatment of PAD by interventionalists. VentureMed is located in Toledo, Ohio, USA.

Our Medical advisory board is comprised of leading international cardiologists, radiologists and vascular surgeons from around the world.

fda clearance

FLEX® has received 510(k) clearance from the U.S. FDA and is available for sale in the United States. 

ce mark

FLEX® has ce mark approval and is registered for sale in the EU.

iso certification

venturemed has received iso 13485 certification for its quality system.

VentureMed Group, Ltd. is pleased to be a member of the ProMedica 
Innovations Incubator in Toledo, Ohio—a state-of-the-art medical device 
development and commercialization center.

VentureMed News

ProMedica Innovations Named EY Entrepreneur of The Year® in the Michigan and Northwest Ohio Region. Click here to read more about this exciting award that our founder and inventor has won.

FLEX Device Discussed in Cath Lab Digest. Click here to read the full article.

VMG Featured In Special Around Promedica Innovations. Click here to watch the video and learn more.